Siga Technologies (SIGA) Invested Capital (2012 - 2019)

Siga Technologies (SIGA) posted Invested Capital of $80.0 million for Q4 2019, down 14.57% on a QoQ basis from $93.7 million in Q3 2016.

Siga Technologies (SIGA) Invested Capital (2012 - 2019) Analysis & Trends

Siga Technologies' Invested Capital history runs 5 years deep, the most recent figure standing at $80.0 million for Q4 2019.

Quarterly Invested Capital changed N/A year-over-year to $80.0 million in Q4 2019, while the trailing twelve-month figure through Sep 2020 was $80.0 million (changed N/A YoY) and the FY2019 annual result came in at $80.0 million, changed N/A from the prior year.
Invested Capital was $80.0 million for Q4 2019 at Siga Technologies, down from $93.7 million in the prior quarter.
Across five years, Invested Capital topped out at $203.7 million in Q2 2016 and bottomed at $80.0 million in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	1.11 Bn
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	2.61 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	31.13 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	7.15 Bn
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	1.93 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	73.00 Mn
10	Siga Technologies	225.56 Mn	70.59 Mn	-	-

Download Data